Imitrex 4 MG/0.5 ML pen inject 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQV1X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,836
Award facts
- Contract value 100% obligated
- $1,835.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $1,835.70 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 22, 2026, for the supply of Imitrex 4 mg/0.5 ml pen injectors. This non-competitive delivery order represents a single task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries an ultimate completion date of January 23, 2026, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. Amerisourcebergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor serving federal healthcare systems including military and Department of Veterans Affairs medical programs.
This delivery order falls within the contractor's established scope as a critical pharmaceutical supplier for federal military healthcare procurement. The DLA Medical Supply Chain utilizes Amerisourcebergen's prime vendor vehicle to source medications and medical supplies across multiple therapeutic domains to support military treatment facilities and defense healthcare operations globally. The firm fixed-price structure and non-set-aside designation indicate the order was awarded under open competition, consistent with Amerisourcebergen's track record of winning federal pharmaceutical contracts through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26FQV1X?
SPE2DR26FQV1X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FQV1X worth?
The government has obligated $1,836 on SPE2DR26FQV1X.
Is contract SPE2DR26FQV1X an order under another contract?
Yes. SPE2DR26FQV1X is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV1X competed?
The extent of competition for SPE2DR26FQV1X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award